$ANTX

2 stories mentioning ANTXUpdated 28d ago

Every FINWIRES story that references ANTX, newest first.

Guggenheim Initiates AN2 Therapeutics at Buy With $9 Price Target

Correction: Leerink Partners Upgrades AN2 Therapeutics to Outperform From Market Perform, Adjusts Price Target to $9 From $1

(Corrects rating change in headline.)(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ANTX

Track with the FINWIRES app suite

FolioX

Track ANTX in your portfolio

WheelAI

Analyze ANTX options with the wheel strategy

StockInsider

See market sentiment on ANTX